DrugApprovals KP (opens the knowledge source's documentation in a new tab) version 1.23.3
This relationship states that Tygacil (opens identifiers.org in a new tab) was applied off label to treat mycobacterial infectious disease (opens monarchinitiative.org in a new tab).
897ef74c-7451-33a0-b314-accff185d73c
Download KGX
Known issue in release 1.23.3. The per-edge linkouts on db.systemsbiology.net do not exist for this version.
Tygacil (opens identifiers.org in a new tab) UMLS:C1614700 (opens identifiers.org in a new tab) , a ChemicalEntity (opens biolink.github.io in a new tab), was applied off label to treat mycobacterial infectious disease (opens monarchinitiative.org in a new tab) MONDO:0020590 (opens monarchinitiative.org in a new tab) , a Disease (opens biolink.github.io in a new tab). This observation is machine generated. The entire dataset underwent manual QC with some human validation. This association was generated by DrugApprovals KP (opens biolink.github.io in a new tab), which integrates the FDA Adverse Event Reporting System (FAERS) (opens biolink.github.io in a new tab), DailyMed (opens biolink.github.io in a new tab), and Canada Vigilance Adverse Reaction Database (opens canada.ca in a new tab).
No FDA application numbers are recorded for this association. FAERS and Canada Vigilance record 11 cases of this usage. No structured-product-label set identifiers are recorded for this association.
Try searching DailyMed for labels mentioning Tygacil (opens dailymed.nlm.nih.gov in a new tab), labels mentioning mycobacterial infectious disease (opens dailymed.nlm.nih.gov in a new tab), or labels mentioning both Tygacil and mycobacterial infectious disease (opens dailymed.nlm.nih.gov in a new tab).
Stored versions
Changes
This is the oldest stored version; there is nothing earlier to compare it with.
About this knowledge graph
The DrugApprovals KP curates assertions of FDA- and EMA-approved treatment relationships, usages observed in FAERS and Health Canada's Canada Vigilance database and applied to treat, and contraindications text-mined from DailyMed labeling; these assertions are derived from DailyMed, Drugs@FDA, FAERS, Canada Vigilance, and the EMA medicines registry.
Something wrong with this relationship? Open an issue. (opens GitHub in a new tab)